1. Home
  2. HBIO vs QTTB Comparison

HBIO vs QTTB Comparison

Compare HBIO & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HBIO
  • QTTB
  • Stock Information
  • Founded
  • HBIO 1901
  • QTTB 2015
  • Country
  • HBIO United States
  • QTTB United States
  • Employees
  • HBIO N/A
  • QTTB N/A
  • Industry
  • HBIO Biotechnology: Laboratory Analytical Instruments
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • HBIO Industrials
  • QTTB Health Care
  • Exchange
  • HBIO Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • HBIO 24.6M
  • QTTB 25.1M
  • IPO Year
  • HBIO 2000
  • QTTB N/A
  • Fundamental
  • Price
  • HBIO $0.76
  • QTTB $2.10
  • Analyst Decision
  • HBIO Buy
  • QTTB Hold
  • Analyst Count
  • HBIO 3
  • QTTB 7
  • Target Price
  • HBIO $2.50
  • QTTB $12.17
  • AVG Volume (30 Days)
  • HBIO 18.9M
  • QTTB 69.2K
  • Earning Date
  • HBIO 11-06-2025
  • QTTB 11-13-2025
  • Dividend Yield
  • HBIO N/A
  • QTTB N/A
  • EPS Growth
  • HBIO N/A
  • QTTB N/A
  • EPS
  • HBIO N/A
  • QTTB N/A
  • Revenue
  • HBIO $87,371,000.00
  • QTTB N/A
  • Revenue This Year
  • HBIO N/A
  • QTTB N/A
  • Revenue Next Year
  • HBIO $7.02
  • QTTB N/A
  • P/E Ratio
  • HBIO N/A
  • QTTB N/A
  • Revenue Growth
  • HBIO N/A
  • QTTB N/A
  • 52 Week Low
  • HBIO $0.28
  • QTTB $1.35
  • 52 Week High
  • HBIO $2.38
  • QTTB $28.66
  • Technical
  • Relative Strength Index (RSI)
  • HBIO 66.85
  • QTTB 41.18
  • Support Level
  • HBIO $0.56
  • QTTB $1.98
  • Resistance Level
  • HBIO $0.74
  • QTTB $2.15
  • Average True Range (ATR)
  • HBIO 0.08
  • QTTB 0.18
  • MACD
  • HBIO 0.01
  • QTTB -0.03
  • Stochastic Oscillator
  • HBIO 95.47
  • QTTB 28.46

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, pharmaceutical and therapy discovery, bioproduction, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life sciences and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, and Panlab. The majority of its revenue comes from the United States.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

Share on Social Networks: